Genesis Healthcare IncGEN:NYQ

6.11
0.02 / 0.33%
75.13k
2.69%
1.85
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 31 2015 21:02 BST.

Summary

On Friday, Genesis Healthcare Inc (GEN:NYQ) closed at 6.11, 6.26% above its 52-week low of 5.75, set on Aug 01, 2014.

52-week range
Today
5.75
Aug 01 2014
9.32
Feb 03 2015
Markit short selling activity
Low
Medium
High
Open6.10
Day high6.19
Day low6.04
Bid--
Offer--
Previous close6.09
Average volume109.27k
Shares outstanding153.55m
Free float56.04m
P/E (TTM)--
Market cap938.21m USD
EPS (TTM)-1.5556 USD
Data delayed at least 15 minutes, as of Jul 31 2015 21:02 BST.

No new headlines available at this time

Search FT.com for Genesis Healthcare Inc

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Genesis Healthcare Inc-10.01 %-7.42 %-26.39 %+2.69 %+129.70 %
S&P 500 INDEX+1.16 %+1.97 %+5.46 %+8.97 %+90.98 %
USA/HEALTH CARE+2.16 %+2.15 %+9.28 %+21.09 %+62.82 %
USA/H CARE PROV & SVC+0.75 %-1.75 %+12.77 %+26.55 %+68.18 %
Data delayed at least 15 minutes, as of Jul 31 2015 21:02 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.